The size of the APAC radiofrequency ablation devices is expected to grow at 14.17% CAGR from 2023 to 2028 and be worth USD 2.03 billion by 2028 from USD 1.05 billion in 2023.
The increasing prevalence of cancer cases is the primary factor in the market's growth. The most common cancers in Asia are lung and breast cancer. Some of the causes of cancer in the population are changing lifestyles, increased smoking and alcohol drinking, reduced physical activities, and an increase in some chronic diseases such as hypertension, diabetes, and lipid disorders. Based on the cancer registry data, nearly 800,000 new cancer cases are reported annually in India.
Increasing minimal invasion procedures is another factor that drives the market forward. Most people prefer to have minimally invasive surgeries due to the fear of significant cuts during the surgeries and the long recovery time. These minimal invasion surgeries require small holes or minor cuts into the body to do the treatment procedure, and it also reduces the recovery time and the hospital stay.
Radiofrequency ablation devices are also used to treat chronic pains caused due to obesity, diabetes, osteoarthritis, and rheumatoid arthritis. This is one of the safe methods for pain management with fewer side effects. Along with this, increasing product approvals and the advancement in ablation devices, such as portability and easy use of the devices with simple instructions, are the other factors that drive the market forward.
Complication after the radiofrequency ablation treatment is the major obstacle to market growth. Some complications after the treatment is swelling, bleeding, and temporary weakness. The high cost of the treatment also hampers the market growth. The lack of skilled professionals and hospital infrastructure are the other reasons for the market growth slowdown.
This research report on the APAC radiofrequency medical devices market has been segmented and sub-segmented into the following categories.
Cardiology & Cardiac Rhythm Management
Rest of APAC
Asia Pacific is in third position in the market's growth due to the introduction of new technologies and increasing investment by the government. Due to the different types of tumors in the body and the way they are existing and growing inside the body, the government decides to spend a large amount of money on research and development of the devices and conduct several clinical trials to get the best outcome in the trials for the effective treatment of this condition. The increasing geriatric population is another reason this regions demand of radiofrequency ablation devices. Older people are more prone to chronic disease and need devices for chronic pain treatment.
In Japan, radiofrequency ablation is used to treat mesothelioma, which is not a chronic tumor but causes pain when it grows. In this treatment process, surgeries provide heat to the malignant cells without causing damage to the surrounding tissues through a small probe insertion into the area where the tumor is located. An increasing number of training centers for radiofrequency ablation to train professionals and help increase the quality of the patient's life is supporting the market growth. In Japan, Juntendo University is now conducting training programs to teach technical aspects of RFA skills to doctors in other institutions and standardize the RFA procedure.
In China, most cancer patients prefer cancer treatment with the help of radiofrequency ablation by using heat generated from the devices to kill the tumor cells. On the other hand, an increasing number of specialists treating tumors using radiofrequency ablation devices in India is the primary factor for the market's growth. As a result, the cost of the procedure is affordable compared to the other neighboring countries.
KEY MARKET PLAYERS:
AngioDynamics, Ethicon, ZenoMed, AtriCure, Inc, Baren-Boym, Huaian Aofu Surgical Instruments Co., Ltd, MedSphere, and Medtronic are a few of the noteworthy players operating in the APAC radiofrequency medical devices market.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com